OOIR: Observatory of International Research

Papers

(The TQCC of Dermatologic Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Copyright	99
The Psoriasis Treatment Pipeline	43
Racial and Ethnic Disparities in Research and Clinical Trials	42
Diversity, Equity, and Inclusion in Dermatology	38
Psoriasis Comorbidities and Their Treatment Impact	36
Coronavirus Disease 2019 and Race in Dermatology	34
Copyright	25
A Canvas of Contemporary Insights into Clinical Vitiligo	23
Adnexal and Sebaceous Carcinomas	22
Gender Equity in Medicine and Dermatology in the United States	22
Cutaneous Sarcoidosis	21
A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma	20
Contents	19
Vascular Anomalies	18
From Geraniums to Guadalajara on the Virtues of Early Retirement	17
Impact of COVID-19 on Dermatology Residency	16
Copyright	16
From Clinic to Hospital and Gold Standard to Substandard: The Complexities of Care of Pediatric Patients	15
Combination Approaches for Combatting Hair Loss	15
Hidradenitis Suppurativa Management with Antibiotics and Systemic Therapies	14
Disparities in Care for Psoriasis	14
Forthcoming Issues	13
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis	13
Copyright	13
Copyright	13

COVID-19 and the Dermatologist	13
Scalp Infection, Inflammation, and Infestation	12
Psoriasis in 2024 and Beyond	12
Histopathology of Vascular Tumors	12
Contributors	11
Contents	11
Diagnosing Disorders of Facial Erythema	11
Contents	11
Coronavirus Disease 2019 and Dermatology Practice Changes	10
Palisaded Neutrophilic Granulomatous Dermatitis, Bowel-Associated Dermatosis–Arthritis Syndrome, and Rheumatoid Neutrophilic Dermatitis	9
Contributors	9
The Food and Drug Administration’s Role in Dermatologic Drug Development	9
Chemical Peels in Treatment of Melasma	8
Starting and Maintaining a Successful Dermatology Practice	8
Cutaneous Oncology Update	8
Energy-based Devices for Hair Loss	7
Histopathology of Vascular Malformations	7
Cutaneous Oncology in the Immunosuppressed	7
Innovations in Acne	7
Incorporating Cosmetic Procedures into Your Dermatology Practice	7
Melanoma classification and management in the era of molecular medicine	6
Laser-based and Light-based Therapies in Hidradenitis Suppurativa	6
Clinical Patterns of Hair Loss in Men	5
Tips, Tricks, and Pearls to Expertly Treat Common Pediatric Dermatologic Conditions	5
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes	5
Food and Drug Administration’s Role in Dermatology	5
Innovation in Warts and Molluscum	5
Diversity, Equity, and Inclusion in Dermatology Residency	5
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?	5
Understanding and Addressing Microaggressions in Medicine	5
Copyright	5
Achieving the Attractive Asian Midface Profile with Hyaluronic Acid–Based Fillers	5
Updates on Lasers in Dermatology	5
Alopecia Areata	5
Private Equity: the Good	5
Capillary Malformations	4
Quality of Life with Neutrophilic Dermatoses	4
Hot Topics in Cosmetic Dermatology	4
Laser Surgery for Dermatologic Conditions in Pediatric Patients	4
Innovation in Dermatomyositis	4
Contributors	4
Addressing Climate-Related Health Impacts During the Patient Encounter	4
The Role of Food Allergy in Atopic Dermatitis	4
Contributors	3
Clinical Patterns and Morphology of COVID-19 Dermatology	3
Targeted Therapy and Immunotherapy in Melanoma	3
Forthcoming Issues	3
Neutrophilic Urticarial Dermatosis	3
Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications	3
Contributors	3

Measuring What Matters to Patients in Dermatology Drug Development	3
Scarring Alopecia	3
Immune Checkpoint Inhibitor-Induced Psoriasis	3
Clinical Decisions in Pediatric Psoriasis	3
Hidradenitis Suppurativa	3
Why I’m Still Practicing	3
Neutrophilic Panniculitides	3
An Evidence-Based Approach to Pediatric Melanonychia	3
Timing of Food Introduction and Allergy Prevention	3
Paradoxical Psoriasis	3
Neurotoxin in the Lower Third of the Face	3
Is Private Practice a Possibility for Me?	3
Morbilliform Eruptions in the Hospitalized Child	3